Archives for September 29, 2022

← 2022

VBI vaccines starts clinical trials for multivalent coronavirus vaccine candidate

29-Sep-2022

By Rachel Arthur

VBI Vaccines has started enrollment in a Phase 1 clinical study of VBI-2901, a multivalent enveloped virus-like particle (eVLP) coronavirus vaccine candidate targeting SARS, COVID-19 and MERS.

FDA grants orphan drug status to CAR-T cell immunotherapy candidate

29-Sep-2022

By Jane Byrne

Penn spinout, Verismo Therapeutics, says the FDA has granted Orphan Drug Designation (ODD) to its KIR-CAR T-cell immunotherapy drug, SynKIR-110, for the treatment of patients with mesothelin-expressing mesotheliomas.